← All organizations
Highest phase reached
Phase 4
Timeline
2000s
- Jan 1, 2000
Emmaus Medical— Founded
- Jun 10, 2004
l-glutamine— NDA Secondary Org
2010s
- Jul 9, 2019
Mynd Analytics— Acquired
Drugs by trial phase (5 distinct, 8 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Marketed drugs (1)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (11)
- NCT04634539CollaboratorPhase 1Jan 1, 2021
- NCT04684381Study chairPhase 4Dec 28, 2020
- NCT04684381Lead sponsorPhase 4Dec 28, 2020
- NCT05106101Study chairPhase 1Jul 19, 2019
- NCT05106101Lead sponsorPhase 1Jul 19, 2019
- NCT01576003CollaboratorN/AApr 1, 2012
- NCT01179217Lead sponsorPhase 3May 1, 2010
- NCT01051999CollaboratorPhase 2Feb 1, 2010
- NCT00125788Overall official - principal investigatorPhase 2Mar 1, 2004
- NCT00125788Lead sponsorPhase 2Mar 1, 2004
- NCT00586209CollaboratorPhase 2Jan 1, 2003
Details
- Founded
- Torrance, CA, US Jan 1, 2000
- Last known activity
- Jan 1, 2021